SynAct Pharma AB (DE:8F8)
FRANKFURT:8F8
Germany Market

SynAct Pharma AB (8F8) Financial Statements

0 Followers

SynAct Pharma AB Financial Overview

SynAct Pharma AB's market cap is currently ―. The company's EPS TTM is €; its P/E ratio is ―; SynAct Pharma AB is scheduled to report earnings on August 20, 2024, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Sep 22Jun 22Mar 22Dec 21
Income Statement-
Total Revenuekr 0.00kr 0.00kr 0.00kr 0.00kr 0.00
Gross Profitkr 0.00kr 0.00kr 0.00kr 0.00-
EBITkr -31.59Mkr -26.46Mkr -26.42Mkr -22.30Mkr -26.16M
EBITDAkr -31.59Mkr -26.46Mkr -26.42Mkr -22.30Mkr -26.16M
Net Income Common Stockholderskr -30.48Mkr -23.92Mkr -24.75Mkr -20.05Mkr -26.21M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investmentskr 108.25Mkr 54.90Mkr 96.47Mkr 6.81Mkr 24.00M
Total Assetskr 142.60Mkr 96.21Mkr 133.97Mkr 22.15Mkr 38.37M
Total Debtkr 2.06Mkr 2.27Mkr 2.17Mkr 2.88Mkr 3.09M
Net Debtkr -106.18Mkr -52.63Mkr -94.29Mkr -3.93Mkr -20.91M
Total Liabilitieskr 16.08Mkr 16.13Mkr 31.32Mkr 21.40Mkr 17.50M
Stockholders Equitykr 126.52Mkr 80.08Mkr 102.65Mkr 758.00Kkr 20.87M
Cash Flow-
Free Cash Flowkr -22.31Mkr -41.34Mkr -36.92Mkr -16.99Mkr -20.26M
Operating Cash Flowkr -22.31Mkr -41.34Mkr -36.92Mkr -16.99Mkr -20.26M
Investing Cash Flowkr 27.00Kkr 0.00kr 0.00kr 0.00kr 2.00K
Financing Cash Flowkr 76.03Mkr -230.00Kkr 125.16Mkr -242.00Kkr -77.00K
Currency in SEK

SynAct Pharma AB Earnings and Revenue History

SynAct Pharma AB Debt to Assets

SynAct Pharma AB Cash Flow

SynAct Pharma AB Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis